BMC Medical Co. Ltd. A (301367) - Total Assets
Based on the latest financial reports, BMC Medical Co. Ltd. A (301367) holds total assets worth CN¥3.38 Billion CNY (≈ $494.09 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check 301367 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
BMC Medical Co. Ltd. A - Total Assets Trend (2020–2025)
This chart illustrates how BMC Medical Co. Ltd. A's total assets have evolved over time, based on quarterly financial data. Check 301367 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
BMC Medical Co. Ltd. A - Asset Composition Analysis
Current Asset Composition (December 2025)
BMC Medical Co. Ltd. A's total assets of CN¥3.38 Billion consist of 90.4% current assets and 9.6% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 31.6% |
| Accounts Receivable | CN¥241.77 Million | 7.1% |
| Inventory | CN¥115.79 Million | 3.4% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥34.03 Million | 1.0% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2020–2025)
This chart illustrates how BMC Medical Co. Ltd. A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see BMC Medical Co. Ltd. A (301367) total market value.
Key Asset Composition Facts
- Current vs. Non-Current Assets: BMC Medical Co. Ltd. A's current assets represent 90.4% of total assets in 2025, a decrease from 93.1% in 2020.
- Cash Position: Cash and equivalents constituted 31.6% of total assets in 2025, down from 46.7% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 2020.
- Asset Diversification: The largest asset category is accounts receivable at 7.1% of total assets.
BMC Medical Co. Ltd. A Competitors by Total Assets
Key competitors of BMC Medical Co. Ltd. A based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087
|
China | CN¥12.68 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥29.91 Billion |
|
Pegavision
TW:6491
|
Taiwan | NT$16.17 Billion |
|
Tarsons Products Limited
NSE:TARSONS
|
India | Rs11.64 Billion |
|
SciVision Biotech Inc
TW:1786
|
Taiwan | NT$2.67 Billion |
|
Nyxoah
BR:NYXH
|
Belgium | €93.60 Million |
|
I.Ceram SA
PA:ALICR
|
France | €3.91 Million |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.33 Billion |
BMC Medical Co. Ltd. A - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 10.81 | 6.60 | 29.19 |
| Quick Ratio | 10.33 | 6.43 | 27.65 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥2.72 Billion | CN¥2.63 Billion | CN¥2.69 Billion |
BMC Medical Co. Ltd. A - Advanced Valuation Insights
This section examines the relationship between BMC Medical Co. Ltd. A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.70 |
| Latest Market Cap to Assets Ratio | 0.22 |
| Asset Growth Rate (YoY) | -1.2% |
| Total Assets | CN¥3.38 Billion |
| Market Capitalization | $732.22 Million USD |
Valuation Analysis
Below Book Valuation: The market values BMC Medical Co. Ltd. A's assets below their book value (0.22x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: BMC Medical Co. Ltd. A's assets decreased by 1.2% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for BMC Medical Co. Ltd. A (2020–2025)
The table below shows the annual total assets of BMC Medical Co. Ltd. A from 2020 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥3.38 Billion ≈ $495.33 Million |
-1.16% |
| 2024-12-31 | CN¥3.42 Billion ≈ $501.16 Million |
+17.35% |
| 2023-12-31 | CN¥2.92 Billion ≈ $427.07 Million |
-0.28% |
| 2022-12-31 | CN¥2.93 Billion ≈ $428.28 Million |
+369.26% |
| 2021-12-31 | CN¥623.69 Million ≈ $91.27 Million |
+33.37% |
| 2020-12-31 | CN¥467.64 Million ≈ $68.43 Million |
-- |
About BMC Medical Co. Ltd. A
BMC Medical Co., Ltd. researches, develops, manufactures, and supplies medical equipment and consumable in the field of respiratory health in China. It offers sleep-disordered breathing (SDB) diagnostic devices, non-invasive ventilators, high-flow nasal cannula oxygen therapy devices, oxygen concentrator, and respiratory consumables, such as various types of masks, breathing tubes, etc., as well … Read more